Journal
JOURNAL OF IMMUNOLOGY
Volume 188, Issue 11, Pages 5538-5546Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1103020
Keywords
-
Categories
Funding
- Israel Science Foundation [773/08, 1702/08]
- Council of Higher Education, Israel
- European Community [224851]
- Milstein Foundation
Ask authors/readers for more resources
TCR-gene transfer represents an effective way to redirect the specificity of T lymphocytes for therapeutic purposes. Recent successful clinical trials have underscored the potential of this approach in which efficient expression of the exogenous TCR has been directly linked to the efficacy of T cell activity. It has been also demonstrated that the TCR exhibits a lack of stability associated with the presence of positively charged residues in its transmembrane (TM) region. In this study, we designed an original approach selectively to improve exogenous TCR stability by increasing the hydrophobic nature of the TCR alpha TM region. Incorporation of hydrophobic residues at evolutionarily permissive positions resulted in an enhanced surface expression of the TCR chains, leading to an improved cellular avidity and anti-tumor TCR activity. Furthermore, this strategy was successfully applied to different TCRs, enabling the targeting of human tumors from different histologies. We also show that the combination of these hydrophobic mutations with another TCR-enhancing approach further improved TCR expression and function. Overall, these findings provide information regarding TCR TM composition that can be applied for the improvement of TCR-gene transfer-based treatments. The Journal of Immunology, 2012, 188: 5538-5546.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available